A mouse model to study immunity against pseudorabies virus infection: Significance of CD4+ and CD8+ cells in protective immunity

Vaccine

Volumn 16, Issue 16, 1998, Pages 1550-1558

  Bianchi, A T J ^a   Moonen Leusen, H W M ^a   Van Milligen, F J ^a   Savelkoul, H F J ^b   Zwart, R J ^a   Kimman, T G ^c  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Cellular immunity; Eudorabies virus; Mouse model

Indexed keywords

ALGINIC ACID; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; OKT 4; OKT 8;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DELAYED HYPERSENSITIVITY; FEMALE; HELPER CELL; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDORABIES; PSEUDORABIES HERPETOVIRUS; SWINE DISEASE; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; HERPESVIRUS 1, SUID; HYPERSENSITIVITY, DELAYED; IMMUNITY, NATURAL; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PSEUDORABIES; PSEUDORABIES VACCINES; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC; VIRAL VACCINES;

EID: 0032192580     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00044-9     Document Type: Article

References (25)

1. 1 Kimman, T.G., Gielkens, A.L.J., Glazenburg, K., Jacobs, L., De Jong, M.C.M., Mulder, W.A.M. and Peeters, B.P.H. Characterization of live pseudorabies virus vaccines. Dev. Biol. Stand. 1995, 84, 89-96.
2. 2 Binns, R.M. and Pabst, R., Lymphoid tissue structure and lymphocyte trafficking in the pig. Vet. Immunol. Immunopathol. 1994, 43, 79-87.
3. + dual expressing T-cells. Vet. Immunol. Immunopathol. 1994, 43, 53-62.
4. + porcine T lymphocytes. Eur. J. Immunol. 1989, 134, 2011-2016.
5. 5 Zuckermann, F.A. and Husmann, R.J. Functional and phenotypic analysis of porcine peripheral blood CD4/CD8 double positive T cells. Immunology 1996, 87, 500-512.
6. + extrathymic T lymphocytes. Cell. Immunol. 1996, 168, 291-296.
7. 7 Kimman, T.G., De Bruin, T.M.G., Voermans, J.J.M., Peeters, B.P.H. and Blanchi, A.T.J. Development and antigen specificity of the lymphoproliferation response of pigs to pseudorabies virus: dichotomy between secondary B-and T-cell responses. Immunology 1995, 86, 372-378.
8. 8 Kimman, T.G., De Bruin, T.G.M., Voermans, J.J.M. and Blanchi, A.T.J. Cell-mediated immunity to pseudorabies virus: cytolytic effector cells with characteristics of lymphokine-activated killer cells lyse virus-infected and glycoprotein gB and gC-transfected L14 cells. J. Gen. Virol. 1996, 77, 978-990.
9. + T cells. J. Immunol. 1993, 150, 2346-2355.
10. + T cell subsets in the control of an acute herpes simplex virus infection in skin and nervous system. J. Gen. Virol. 1987, 68, 825-833.
11. 11 Manickan, E. and Rouse, B.T. Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse models. J. Virol. 1995, 69, 8178-8179.
12. 12 Schijns, V.E.C.J., Haagmans, B.L., Rijke, E.O., Huang, S., Aguet, M. and Horzinek, M.C. IFN-g receptor deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses. J. Immunol. 1994, 153, 2029-2037.
13. 13 Zuckermann, F.A., Zsak, L., Mettenleiter, T.C. and Ben Porat, T. Pseudorabies virus glycoprotein gill is a major target antigen for murine and swine virus-specific cytotoxic T lymphocytes. J. Virol. 1990, 64, 802-812.
14. 14 Savelkoul, H.F.J., Van Ommen, R., Vossen, A.C.T.M., Breedland, E.G., Coffman, R.L. and Van Oudenaren, A. Modulation of systemic cytokine levels by implantation of alginate encapsulated cells. J. Immunol. Meth. 1994, 170, 185-196.
15. 15 Moormann, R.J.M., De Rover, T., Briaire, J., Peeters, B.P.H., Gielkens, A.L.J. and Van Oirschot, J.T. Inactivation of the thymidine kinase deletion mutant of pseudorabies virus generates a safe but highly immunogenic vaccine strain. J. Gen. Virol. 1990, 71, 1591-1595.
16. 16 Mosmann, T.R. and Coffman, R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annual Rev. Immunol. 1989, 7, 145-173.
17. 17 Hendrzak, J.A. and Morahan, P.S. The role of macrophages and macrophage cytokines in host resitance to herpes simplex virus. Immunology series. Vol. 60, Marcel Dekker, New York, 1994, pp. 601-617.
18. 18 Finkelman, F.D., Katona, I.M., Mosmann, T.R. and Coffman, R.L. IFN-gamma regulates the isotypes of Ig during in vivo humoral immune responses. J. Immunol. 1988, 140, 1022-1027.
19. 19 Mishkin, E.M., Blasiak, M., Girgio, D. and Ishizaka, S.T. Effects of in vivo depletion of immunocyte populations on herpes simplex virus glycoprotein D vaccine-induced resistance to HSV2 challenge. Viral Immunol. 1992, 5, 151-161.
20. 20 Schrier, R.D., Ishioka, G.Y., Pizer, L.I. and Moorhead, J.W. Delayed type hypersensitivity and immune protection against herpes simplex virus: suppressor T cells that regulate the induction of delayed hypersensitivity effector T cells also regulate the induction of protective T cells. J. Immunol. 1985, 134, 2889-2893.
21. 21 Coutelier, J-P., Vander Logt, J.T.M., Heessen, F.W.A., Warner, G. and Snick, J. IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 1987, 165, 64-69.
22. 22 Eis-Huebinger, A.M., Schmidt, D.S. and Schneweis, K.E. Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection of virus replication at the inoculated mucous membranes. J. Gen. Virol. 1993, 74, 379-385.
23. 23 Schijns, V.E.C.J., Haagmans, B.L. and Horzinek, M.C. IL-12 stimulates an anti-viral type 1 cytokine response but lacks adjuvant activity in IFN-g-receptor-deficient mice. J. Immunol. 1995, 155, 2525-2532.
24. 24 Rinaldo, C.R. and Torpey, D.J. Cell-mediated immunity and immunosuppression in herpes simplex virus infection. Immunodefiency 1993, 5, 33-90.
25. 25 Straton, G.J., Jordan, C., Hart, A., Heard, H., Langford, M.P. and Baron, S. Non-detectable levels of IFNg is a critical host defence during the first day of herpes simplex infection. Microbial Pathogenisis 1987, 3, 179-183.